本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

13.59
+1.199.60%
盤後13.700.1096+0.81%18:23 EDT
成交量:534.59萬
成交額:7,232.76萬
市值:12.06億
市盈率:-4.04
高:13.90
開:13.59
低:12.85
收:12.40
52周最高:13.90
52周最低:7.36
股本:8,877.44萬
流通股本:7,060.22萬
量比:1.78
換手率:7.57%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
淨資產收益率:-167.71%
總資產收益率:-31.30%
市淨率:24.91
市盈率(LYR):-4.28

資料載入中...

2024/08/09

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

重要事件披露

Form 8-K - Current report